Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-01

FDA Approved: POTASSIUM CHLORIDE EXTENDED-RELEASE — Supplemental Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Potassium Chloride Extended-Release from Upsher-Smith Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Potassium Chloride Extended Release (Potassium chloride)

Snippet

SUPPL AP for POTASSIUM CHLORIDE EXTENDED-RELEASE (POTASSIUM CHLORIDE)